Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke

Terminated

Phase 1 Results N/A

Summary of Purpose

Stroke is the third leading cause of death in the United States and the leading cause of serious long-term disability. Approximately 50% of the 750,000 people affected by stroke each year have residual physical impairment. Treatment options for recovery are limited at this time. Sildenafil (Viagra) has demonstrated the... Trial Stopped: Failure to recruit in expected time period.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 March 2011.

1 Apr 2005 26 Mar 2007 Unavailable Unavailable 1 Mar 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment

Contacts

Not available